Global On-body Injectors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronical Injectors, Mechanical Injectors), Diabetes (Electronical Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.
Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronical Injectors, Mechanical Injectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.
Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to On-body Injectors:
Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Diabetes).
Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2019 to 2024.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
An on-body Injector is a small, lightweight delivery system applied to the skin.
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronical Injectors, Mechanical Injectors), Diabetes (Electronical Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.
Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronical Injectors, Mechanical Injectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.
Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to On-body Injectors:
Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Diabetes).
Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Electronical Injectors
- Mechanical Injectors
- Others
- Immuno-oncology
- Diabetes
- Cardiovascular Diseases
- Others
- BD Medical
- Medtronic
- Insulet
- Sensile Medical
- Ypsomed
- Enable Injections
- Roche
- ScPharmaceuticals
- SteadyMed
- CeQur
- Tandem Diabetes Care
- Valeritas
- SteadyMed Therapeutics
- Amgen
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2019 to 2024.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of On-body Injectors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Electronical Injectors
1.3.3 Mechanical Injectors
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immuno-oncology
1.4.3 Diabetes
1.4.4 Cardiovascular Diseases
1.4.5 Others
1.5 Global On-body Injectors Market Size & Forecast
1.5.1 Global On-body Injectors Consumption Value (2019 & 2023 & 2030)
1.5.2 Global On-body Injectors Sales Quantity (2019-2030)
1.5.3 Global On-body Injectors Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 BD Medical
2.1.1 BD Medical Details
2.1.2 BD Medical Major Business
2.1.3 BD Medical On-body Injectors Product and Services
2.1.4 BD Medical On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Medical Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic On-body Injectors Product and Services
2.2.4 Medtronic On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Recent Developments/Updates
2.3 Insulet
2.3.1 Insulet Details
2.3.2 Insulet Major Business
2.3.3 Insulet On-body Injectors Product and Services
2.3.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Insulet Recent Developments/Updates
2.4 Sensile Medical
2.4.1 Sensile Medical Details
2.4.2 Sensile Medical Major Business
2.4.3 Sensile Medical On-body Injectors Product and Services
2.4.4 Sensile Medical On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sensile Medical Recent Developments/Updates
2.5 Ypsomed
2.5.1 Ypsomed Details
2.5.2 Ypsomed Major Business
2.5.3 Ypsomed On-body Injectors Product and Services
2.5.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Ypsomed Recent Developments/Updates
2.6 Enable Injections
2.6.1 Enable Injections Details
2.6.2 Enable Injections Major Business
2.6.3 Enable Injections On-body Injectors Product and Services
2.6.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Enable Injections Recent Developments/Updates
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche On-body Injectors Product and Services
2.7.4 Roche On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments/Updates
2.8 ScPharmaceuticals
2.8.1 ScPharmaceuticals Details
2.8.2 ScPharmaceuticals Major Business
2.8.3 ScPharmaceuticals On-body Injectors Product and Services
2.8.4 ScPharmaceuticals On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ScPharmaceuticals Recent Developments/Updates
2.9 SteadyMed
2.9.1 SteadyMed Details
2.9.2 SteadyMed Major Business
2.9.3 SteadyMed On-body Injectors Product and Services
2.9.4 SteadyMed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 SteadyMed Recent Developments/Updates
2.10 CeQur
2.10.1 CeQur Details
2.10.2 CeQur Major Business
2.10.3 CeQur On-body Injectors Product and Services
2.10.4 CeQur On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CeQur Recent Developments/Updates
2.11 Tandem Diabetes Care
2.11.1 Tandem Diabetes Care Details
2.11.2 Tandem Diabetes Care Major Business
2.11.3 Tandem Diabetes Care On-body Injectors Product and Services
2.11.4 Tandem Diabetes Care On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Tandem Diabetes Care Recent Developments/Updates
2.12 Valeritas
2.12.1 Valeritas Details
2.12.2 Valeritas Major Business
2.12.3 Valeritas On-body Injectors Product and Services
2.12.4 Valeritas On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Valeritas Recent Developments/Updates
2.13 SteadyMed Therapeutics
2.13.1 SteadyMed Therapeutics Details
2.13.2 SteadyMed Therapeutics Major Business
2.13.3 SteadyMed Therapeutics On-body Injectors Product and Services
2.13.4 SteadyMed Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SteadyMed Therapeutics Recent Developments/Updates
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business
2.14.3 Amgen On-body Injectors Product and Services
2.14.4 Amgen On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Amgen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ON-BODY INJECTORS BY MANUFACTURER
3.1 Global On-body Injectors Sales Quantity by Manufacturer (2019-2024)
3.2 Global On-body Injectors Revenue by Manufacturer (2019-2024)
3.3 Global On-body Injectors Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2023
3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2023
3.5 On-body Injectors Market: Overall Company Footprint Analysis
3.5.1 On-body Injectors Market: Region Footprint
3.5.2 On-body Injectors Market: Company Product Type Footprint
3.5.3 On-body Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global On-body Injectors Market Size by Region
4.1.1 Global On-body Injectors Sales Quantity by Region (2019-2030)
4.1.2 Global On-body Injectors Consumption Value by Region (2019-2030)
4.1.3 Global On-body Injectors Average Price by Region (2019-2030)
4.2 North America On-body Injectors Consumption Value (2019-2030)
4.3 Europe On-body Injectors Consumption Value (2019-2030)
4.4 Asia-Pacific On-body Injectors Consumption Value (2019-2030)
4.5 South America On-body Injectors Consumption Value (2019-2030)
4.6 Middle East and Africa On-body Injectors Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global On-body Injectors Sales Quantity by Type (2019-2030)
5.2 Global On-body Injectors Consumption Value by Type (2019-2030)
5.3 Global On-body Injectors Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global On-body Injectors Sales Quantity by Application (2019-2030)
6.2 Global On-body Injectors Consumption Value by Application (2019-2030)
6.3 Global On-body Injectors Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America On-body Injectors Sales Quantity by Type (2019-2030)
7.2 North America On-body Injectors Sales Quantity by Application (2019-2030)
7.3 North America On-body Injectors Market Size by Country
7.3.1 North America On-body Injectors Sales Quantity by Country (2019-2030)
7.3.2 North America On-body Injectors Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe On-body Injectors Sales Quantity by Type (2019-2030)
8.2 Europe On-body Injectors Sales Quantity by Application (2019-2030)
8.3 Europe On-body Injectors Market Size by Country
8.3.1 Europe On-body Injectors Sales Quantity by Country (2019-2030)
8.3.2 Europe On-body Injectors Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific On-body Injectors Market Size by Region
9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America On-body Injectors Sales Quantity by Type (2019-2030)
10.2 South America On-body Injectors Sales Quantity by Application (2019-2030)
10.3 South America On-body Injectors Market Size by Country
10.3.1 South America On-body Injectors Sales Quantity by Country (2019-2030)
10.3.2 South America On-body Injectors Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa On-body Injectors Market Size by Country
11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 On-body Injectors Market Drivers
12.2 On-body Injectors Market Restraints
12.3 On-body Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of On-body Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of On-body Injectors
13.3 On-body Injectors Production Process
13.4 On-body Injectors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 On-body Injectors Typical Distributors
14.3 On-body Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of On-body Injectors
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Electronical Injectors
1.3.3 Mechanical Injectors
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immuno-oncology
1.4.3 Diabetes
1.4.4 Cardiovascular Diseases
1.4.5 Others
1.5 Global On-body Injectors Market Size & Forecast
1.5.1 Global On-body Injectors Consumption Value (2019 & 2023 & 2030)
1.5.2 Global On-body Injectors Sales Quantity (2019-2030)
1.5.3 Global On-body Injectors Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 BD Medical
2.1.1 BD Medical Details
2.1.2 BD Medical Major Business
2.1.3 BD Medical On-body Injectors Product and Services
2.1.4 BD Medical On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Medical Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic On-body Injectors Product and Services
2.2.4 Medtronic On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medtronic Recent Developments/Updates
2.3 Insulet
2.3.1 Insulet Details
2.3.2 Insulet Major Business
2.3.3 Insulet On-body Injectors Product and Services
2.3.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Insulet Recent Developments/Updates
2.4 Sensile Medical
2.4.1 Sensile Medical Details
2.4.2 Sensile Medical Major Business
2.4.3 Sensile Medical On-body Injectors Product and Services
2.4.4 Sensile Medical On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Sensile Medical Recent Developments/Updates
2.5 Ypsomed
2.5.1 Ypsomed Details
2.5.2 Ypsomed Major Business
2.5.3 Ypsomed On-body Injectors Product and Services
2.5.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Ypsomed Recent Developments/Updates
2.6 Enable Injections
2.6.1 Enable Injections Details
2.6.2 Enable Injections Major Business
2.6.3 Enable Injections On-body Injectors Product and Services
2.6.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Enable Injections Recent Developments/Updates
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche On-body Injectors Product and Services
2.7.4 Roche On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Roche Recent Developments/Updates
2.8 ScPharmaceuticals
2.8.1 ScPharmaceuticals Details
2.8.2 ScPharmaceuticals Major Business
2.8.3 ScPharmaceuticals On-body Injectors Product and Services
2.8.4 ScPharmaceuticals On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ScPharmaceuticals Recent Developments/Updates
2.9 SteadyMed
2.9.1 SteadyMed Details
2.9.2 SteadyMed Major Business
2.9.3 SteadyMed On-body Injectors Product and Services
2.9.4 SteadyMed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 SteadyMed Recent Developments/Updates
2.10 CeQur
2.10.1 CeQur Details
2.10.2 CeQur Major Business
2.10.3 CeQur On-body Injectors Product and Services
2.10.4 CeQur On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CeQur Recent Developments/Updates
2.11 Tandem Diabetes Care
2.11.1 Tandem Diabetes Care Details
2.11.2 Tandem Diabetes Care Major Business
2.11.3 Tandem Diabetes Care On-body Injectors Product and Services
2.11.4 Tandem Diabetes Care On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Tandem Diabetes Care Recent Developments/Updates
2.12 Valeritas
2.12.1 Valeritas Details
2.12.2 Valeritas Major Business
2.12.3 Valeritas On-body Injectors Product and Services
2.12.4 Valeritas On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Valeritas Recent Developments/Updates
2.13 SteadyMed Therapeutics
2.13.1 SteadyMed Therapeutics Details
2.13.2 SteadyMed Therapeutics Major Business
2.13.3 SteadyMed Therapeutics On-body Injectors Product and Services
2.13.4 SteadyMed Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 SteadyMed Therapeutics Recent Developments/Updates
2.14 Amgen
2.14.1 Amgen Details
2.14.2 Amgen Major Business
2.14.3 Amgen On-body Injectors Product and Services
2.14.4 Amgen On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Amgen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ON-BODY INJECTORS BY MANUFACTURER
3.1 Global On-body Injectors Sales Quantity by Manufacturer (2019-2024)
3.2 Global On-body Injectors Revenue by Manufacturer (2019-2024)
3.3 Global On-body Injectors Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2023
3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2023
3.5 On-body Injectors Market: Overall Company Footprint Analysis
3.5.1 On-body Injectors Market: Region Footprint
3.5.2 On-body Injectors Market: Company Product Type Footprint
3.5.3 On-body Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global On-body Injectors Market Size by Region
4.1.1 Global On-body Injectors Sales Quantity by Region (2019-2030)
4.1.2 Global On-body Injectors Consumption Value by Region (2019-2030)
4.1.3 Global On-body Injectors Average Price by Region (2019-2030)
4.2 North America On-body Injectors Consumption Value (2019-2030)
4.3 Europe On-body Injectors Consumption Value (2019-2030)
4.4 Asia-Pacific On-body Injectors Consumption Value (2019-2030)
4.5 South America On-body Injectors Consumption Value (2019-2030)
4.6 Middle East and Africa On-body Injectors Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global On-body Injectors Sales Quantity by Type (2019-2030)
5.2 Global On-body Injectors Consumption Value by Type (2019-2030)
5.3 Global On-body Injectors Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global On-body Injectors Sales Quantity by Application (2019-2030)
6.2 Global On-body Injectors Consumption Value by Application (2019-2030)
6.3 Global On-body Injectors Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America On-body Injectors Sales Quantity by Type (2019-2030)
7.2 North America On-body Injectors Sales Quantity by Application (2019-2030)
7.3 North America On-body Injectors Market Size by Country
7.3.1 North America On-body Injectors Sales Quantity by Country (2019-2030)
7.3.2 North America On-body Injectors Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe On-body Injectors Sales Quantity by Type (2019-2030)
8.2 Europe On-body Injectors Sales Quantity by Application (2019-2030)
8.3 Europe On-body Injectors Market Size by Country
8.3.1 Europe On-body Injectors Sales Quantity by Country (2019-2030)
8.3.2 Europe On-body Injectors Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific On-body Injectors Market Size by Region
9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America On-body Injectors Sales Quantity by Type (2019-2030)
10.2 South America On-body Injectors Sales Quantity by Application (2019-2030)
10.3 South America On-body Injectors Market Size by Country
10.3.1 South America On-body Injectors Sales Quantity by Country (2019-2030)
10.3.2 South America On-body Injectors Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa On-body Injectors Market Size by Country
11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 On-body Injectors Market Drivers
12.2 On-body Injectors Market Restraints
12.3 On-body Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of On-body Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of On-body Injectors
13.3 On-body Injectors Production Process
13.4 On-body Injectors Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 On-body Injectors Typical Distributors
14.3 On-body Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
